Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
831.2 INR | -0.08% | -1.60% | -20.95% |
Apr. 03 | Anupam Rasayan Signs LOI Worth $90 Million with Japanese Multinational Company | MT |
Apr. 02 | Anupam Rasayan India Limited Signs LOI with Prominent Japanese Multinational Worth $90 Million | CI |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
Weaknesses
- With an expected P/E ratio at 67.39 and 42.63 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-20.95% | 1.09B | C+ | ||
+11.76% | 63.38B | A- | ||
-3.69% | 46.51B | A- | ||
+13.32% | 39.91B | B+ | ||
+19.57% | 25.57B | A- | ||
+8.37% | 18.95B | C+ | ||
+1.44% | 17.58B | B+ | ||
-20.33% | 16.1B | A- | ||
+0.91% | 14.98B | B+ | ||
-12.98% | 14.78B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ANURAS Stock
- ANURAS Stock
- Ratings Anupam Rasayan India Limited